Beijing Financial Statements From 2010 to 2025
603392 Stock | 66.88 0.16 0.24% |
Check Beijing Wantai financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Beijing Wantai's main balance sheet or income statement drivers, such as , as well as many indicators such as . Beijing financial statements analysis is a perfect complement when working with Beijing Wantai Valuation or Volatility modules.
Beijing |
Beijing Wantai Biological Company Current Valuation Analysis
Beijing Wantai's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Beijing Wantai Current Valuation | 80.24 B |
Most of Beijing Wantai's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beijing Wantai Biological is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Beijing Wantai Biological has a Current Valuation of 80.24 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is significantly lower than that of the firm.
Beijing Wantai Biological Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Beijing Wantai's current stock value. Our valuation model uses many indicators to compare Beijing Wantai value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Beijing Wantai competition to find correlations between indicators driving Beijing Wantai's intrinsic value. More Info.Beijing Wantai Biological is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Beijing Wantai by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Beijing Wantai's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Beijing Wantai Financial Statements
Beijing Wantai stakeholders use historical fundamental indicators, such as Beijing Wantai's revenue or net income, to determine how well the company is positioned to perform in the future. Although Beijing Wantai investors may analyze each financial statement separately, they are all interrelated. For example, changes in Beijing Wantai's assets and liabilities are reflected in the revenues and expenses on Beijing Wantai's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Beijing Wantai Biological. Please read more on our technical analysis and fundamental analysis pages.
Currently Active Assets on Macroaxis
Other Information on Investing in Beijing Stock
Beijing Wantai financial ratios help investors to determine whether Beijing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Beijing with respect to the benefits of owning Beijing Wantai security.